2016
DOI: 10.1038/srep27348
|View full text |Cite
|
Sign up to set email alerts
|

Inlay osteotome sinus floor elevation with concentrated growth factor application and simultaneous short implant placement in severely atrophic maxilla

Abstract: Sinus floor elevation with simultaneous implant placement in severely atrophic maxilla is challenging. The aim of this retrospective study was to evaluate the short-term performance of modified osteotome sinus floor elevation (OSFE) with concentrated growth factor (CGF) application and concurrent placement of a short implant in cases with residual bone height (RBH) of 2–4 mm. Twenty-five short implants were installed in 16 patients with mean RBH of 3.23 mm using modified OSFE with CGFs from January 2012 to Apr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
23
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 40 publications
2
23
0
Order By: Relevance
“…This finding is also in agreement with those of previous investigations indicating that A‐PRF and CGF are beneficial for alveolar bone regeneration . ‒ However, there is minimal information regarding their optimal clinical application in periodontal IBDs. This study represents the first retrospective study comparing clinical effectiveness of A‐PRF and CGF, indicating which both have the potential application value as a desired GTR biomaterial by the promotion of vital bone formation at the treated BD site.…”
Section: Discussionsupporting
confidence: 92%
“…This finding is also in agreement with those of previous investigations indicating that A‐PRF and CGF are beneficial for alveolar bone regeneration . ‒ However, there is minimal information regarding their optimal clinical application in periodontal IBDs. This study represents the first retrospective study comparing clinical effectiveness of A‐PRF and CGF, indicating which both have the potential application value as a desired GTR biomaterial by the promotion of vital bone formation at the treated BD site.…”
Section: Discussionsupporting
confidence: 92%
“…Three different protocols were used for each volunteer (V1, V2, and V3) to produce the CGF, varying for each one the blood collection tube composition and morphology: PROTOCOL 1: sterile Vacuette tubes (Greiner Bio‐One, GmbH, Kremsmunster, Austria) coated with silica microparticles (SCTs) as a serum clot activator were used for blood collection (Borsani et al, ; Chen et al, ; Rodella et al, ) (Figure a). PROTOCOL 2: glass tubes with a round bottom (GRBTs) (Silfradent srl, Forli, Italy) were used for blood collection (Figure b) PROTOCOL 3: glass tubes with a conical bottom (GCBTs) (Silfradent srl, Forli, Italy) were used for blood collection (Figure c) …”
Section: Methodsmentioning
confidence: 99%
“…PROTOCOL 1: sterile Vacuette tubes (Greiner Bio‐One, GmbH, Kremsmunster, Austria) coated with silica microparticles (SCTs) as a serum clot activator were used for blood collection (Borsani et al, ; Chen et al, ; Rodella et al, ) (Figure a).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Honda etal 2013 7 Found that CGF promoted proliferation, osteogenic maturation and mineralization of mesenchymal stem cells in vitro more over the authors found that combining CGFs with bone marrow stroma cells resulted in excellent healing of critical sized bone defects in vivo. 8 Evaluated short term performance of implants placed after modified osteotome sinus floor elevation with CGFs in atrophic maxilla. The results showed high survival rate for these cases.…”
Section: Introductionmentioning
confidence: 99%